Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection

Treatment with pegylated interferon alpha-2b (PEGIFN) plus ribavirin (RBV) is standard therapy for patients with chronic hepatitis C. Although the effectiveness, patients with high titres of group Ib hepatitis C virus (HCV) respond poorly compared to other genotypes. At present, we cannot predict th...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Tetsuro, Ebinuma, Hirotoshi, Tada, Shinichiro, Yamagishi, Yoshiyuki, Wakabayashi, Kanji, Ojiro, Keisuke, Kanai, Takanori, Saito, Hidetsugu, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229481/
https://www.ncbi.nlm.nih.gov/pubmed/22164207
http://dx.doi.org/10.1371/journal.pone.0027223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229481/
https://www.ncbi.nlm.nih.gov/pubmed/22164207
http://dx.doi.org/10.1371/journal.pone.0027223

Ejemplares similares